Comerica Bank’s Denali Therapeutics DNLI Stock Holding History

Comerica Bank’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$21.2K	Hold	1,284	–	–	﹤0.01%	3071
2025 Q3	$18.6K	Hold	1,284	–	–	﹤0.01%	3106
2025 Q2	$18K	Buy	1,284 +100	+8%	+$1.41K	﹤0.01%	3077
2025 Q1	$16.1K	Buy	1,184 +89	+8%	+$1.71K	﹤0.01%	3066
2024 Q4	$22.3K	Buy	1,095 +6	+0.6%	+$154	﹤0.01%	3001
2024 Q3	$31.7K	Buy	1,089 +674	+162%	+$16.7K	﹤0.01%	2904
2024 Q2	$9.64K	Buy	415 +6	+1%	+$115	﹤0.01%	3160
2024 Q1	$8.39K	Sell	409 -202	-33%	-$3.8K	﹤0.01%	3218
2023 Q4	$13.1K	Buy	611 +293	+92%	+$5.8K	﹤0.01%	3090
2023 Q3	$6.57K	Buy	+318	New	+$8.07K	﹤0.01%	3295

Other funds holding DNLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Comerica Bank's DNLI Position: Q4 2025 in Review

Comerica Bank held its Denali Therapeutics (DNLI) position steady in Q4 2025 at 1,284 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3071.

Comerica Bank first reported a position in DNLI in Q3 2023 and has held it in 10 quarters since. The position peaked at $31.7K in Q3 2024. 250 funds tracked by Wall St. Rank hold DNLI as of Q4 2025.

Comerica Bank held 1,284 shares of Denali Therapeutics worth $21.2K as of Q4 2025.
Comerica Bank left its Denali Therapeutics share count unchanged in Q4 2025.
Denali Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3071 holding.
Comerica Bank first reported a position in Denali Therapeutics in Q3 2023 and has held it in 10 quarters since.
Comerica Bank's Denali Therapeutics position peaked at $31.7K in Q3 2024.
250 funds tracked by Wall St. Rank held Denali Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.